v3.26.3
Capital Stock (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended 55 Months Ended
Aug. 07, 2026
Jul. 20, 2026
May 19, 2026
Oct. 16, 2025
Apr. 03, 2025
Apr. 02, 2025
Jan. 03, 2025
Sep. 30, 2026
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Apr. 30, 2026
Dec. 31, 2025
Class of Stock [Line Items]                          
Common stock, shares authorized               3,000,000,000 3,000,000,000   3,000,000,000   3,000,000,000
Common stock, par value               $ 0.001 $ 0.001   $ 0.001   $ 0.001
Preferred stock, shares authorized               30,000,000 30,000,000   30,000,000    
Preferred stock, par value               $ 0.10 $ 0.10   $ 0.10    
Proceeds from warrant exercise                 $ 2,719,185 $ 2,195,312 $ 20,856,176    
Proceeds from issuance of common stock                 7,316,895 $ 1,828,596      
At-The-Market Issuance Sales Agreement Terms   On July 20, 2026, the Company entered into an At-The-Market Issuance Sales Agreement (the “Sales Agreement”) with Aegis Capital Corp. (the “Agent”), under which the Company may, from time to time, sell shares of the Company’s common stock, for an aggregate offering price of up to $4,000,000, in “at-the-market” offerings through or to the Agent, as exclusive sales agent (the “ATM Offering”). Subject to the terms and conditions of the Sales Agreement and the applicable placement notice, sales of the Company’s common stock may be made by any method permitted by law deemed to be an “at-the-market offering” as defined in Rule 415(a)(4) under the Securities Act of 1933, as amended, including sales made directly on or through the Nasdaq Capital Market or any other existing trading market for the Company’s common stock. The Agent will receive a commission from the Company of 3.0% of the gross proceeds from the sale of any shares of common stock under the Sales Agreement, in addition to reimbursement of certain expenses.                      
Common stock issued through ATM offering               $ 2,231,895 $ 2,231,895        
Common stock, shares issued               278,317 278,317   278,317   24,530
Common stock, shares outstanding               278,317 278,317   278,317   24,530
Dividends declared                 $ 0        
2026 Public Offering [Member]                          
Class of Stock [Line Items]                          
Proceeds from sale of equity     $ 6,000,000                    
Series B Warrant Exercises [Member]                          
Class of Stock [Line Items]                          
Stock converted, shares converted       1,750   3,300 638            
Proceeds from warrant exercise       $ 724,500   $ 1,840,014 $ 355,298            
Director [Member]                          
Class of Stock [Line Items]                          
Shares issued                       500  
Shares issued 2,915                        
Series B Preferred Stock [Member]                          
Class of Stock [Line Items]                          
Preferred stock, shares authorized               1,000,000 1,000,000   1,000,000   1,000,000
Preferred stock, par value               $ 0.10 $ 0.10   $ 0.10   $ 0.10
Preferred stock, shares outstanding               130,000 130,000   130,000   130,000
Series B Preferred Stock [Member] | Chief Executive Officer [Member]                          
Class of Stock [Line Items]                          
Preferred stock, shares outstanding               130,000 130,000   130,000   130,000
Common Stock [Member]                          
Class of Stock [Line Items]                          
Common stock issued through ATM offering, shares               93,174          
Common stock issued through ATM offering               $ 2,231,895          
Common Stock [Member] | Registered Direct Offering [Member]                          
Class of Stock [Line Items]                          
Stock issued new, shares         5,942                
Proceeds from issuance of common stock         $ 1,828,596                
Common Stock [Member] | Series B Warrant Exercises [Member]                          
Class of Stock [Line Items]                          
Stock converted, shares issued       1,750   3,300 638            
Common Units [Member] | 2026 Public Offering [Member]                          
Class of Stock [Line Items]                          
Stock issued new, shares     60,000                    
Description of Units     each consisting of (i) one (1) share of common stock or one (1) pre-funded warrant and (ii) two (2) Series C Warrants to purchase one (1) share of common stock per warrant at an initial exercise price of $100.00.